Skip to content
healthcare.dev

Opsin II 6015

NDC 63083-6015, Opsin II, liquid, from Professional Complementary Health Formulas.

Product NDC
63083-6015
Status
Listed
Labeler
Professional Complementary Health Formulas
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63083-6015 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ONION3 [hp_X]/59mL
  • AMBROSIA ARTEMISIIFOLIA WHOLE3 [hp_X]/59mL
  • EUPHRASIA STRICTA3 [hp_X]/59mL
  • WYETHIA HELENIOIDES ROOT3 [hp_X]/59mL
  • NAPHTHALENE4 [hp_X]/59mL
  • EPINEPHRINE6 [hp_X]/59mL
  • ARUNDO PLINIANA ROOT6 [hp_X]/59mL
  • SCHOENOCAULON OFFICINALE SEED6 [hp_X]/59mL
  • ARSENIC TRIOXIDE12 [hp_X]/59mL
  • HISTAMINE DIHYDROCHLORIDE12 [hp_X]/59mL
  • SODIUM CHLORIDE12 [hp_X]/59mL
  • TOBACCO LEAF12 [hp_X]/59mL

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Allergens [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Vegetable Proteins [CS]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
63083-6015-26308360150259 mL in 1 BOTTLE, DROPPER (63083-6015-2)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63083-6015 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63083-6015 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63083-6015. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.